Tennessee governor Bill Lee, Department of Economic and Community Development commissioner Bob Rolfe, and August Bioservices LLC officials have announced that the August Bioservices will significantly expand its operations in Nashville.
 
Headquartered in Nashville, August Bioservices will invest $64.7 million and create 180 jobs over the next five years.
 
Investment and Expansion
 
The first phase of the project, which will be completed in late 2021, will involve the targeted expansion of August Bioservices’ existing Nashville facility, adding high-value technologies such as lyophilization and terminal sterilization to its existing cGMP fill and finish manufacturing capabilities.
 
The second phase of the project will see August Bioservices construct a new drug development and manufacturing facility that will feature multiple high-speed production lines capable of delivering commercial scale throughput across a wide array of sterile injectables containers, including vials, IV bags and prefilled syringes.
 
Taken together, the expansion activities will enable August Bioservices to grow its footprint in drug development and manufacturing services and allow the company to pursue attractive later-stage clinical development as well as commercial manufacturing opportunities.
 
August Bioservices is a contract development and manufacturing organization (CDMO) providing drug discovery, drug development and drug manufacturing services in support of the global pharmaceutical industry. The company is expanding its capabilities to become a preferred, specialized, one-stop-shop CDMO for clinical and commercial injectable therapies.